| Mrs Bethany Anne Thompson, APRN, CNM | |
|
601 Jacob Ln, Anoka, MN 55303-1776 | |
| (763) 587-4200 | |
| (763) 587-4205 |
| Full Name | Mrs Bethany Anne Thompson |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 3 Years |
| Location | 601 Jacob Ln, Anoka, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740937291 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 500 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthpartners Medical Group | 1759293954 | 1430 |
News Archive
Researchers at the Swansea University have shown that Manuka honey could be useful in treatment of deadly lung infections caused by antimicrobial resistant respiratory bacteria in cystic fibrosis (CF). The study titled, "Anti-pseudomonad Activity of Manuka Honey and Antibiotics in a Specialized ex vivo Model Simulating Cystic Fibrosis Lung Infection," was published in the latest issue of the journal Frontiers of Microbiology.
GenomeDx Biosciences today announced that data presented at the 2015 American Society of Clinical Oncology Annual Meeting demonstrate that the Decipher® Prostate Cancer Classifier is a significant predictor of metastasis in patients treated with postoperative salvage radiation therapy.
Corcept Therapeutics Incorporated, a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, today announced results of a multi-center Phase 1/2 dose-escalation study of mifepristone and chemotherapy drug eribulin (Halaven) that show it is well tolerated and clinically active in patients with triple-negative breast cancer.
Cell-based therapies have yet to reach their full potential in repairing damaged tissue because of the hostile environment the cells face once injected into the body. A patient's inflammatory response normally causes the majority of these therapeutic cells to die or migrate away from the area in need of repair.
Indiana University has arranged for a media availability on Monday (May 10) at 1:30 p.m. in Indianapolis with Randall L. Tobias, U.S. Global AIDS coordinator and chairman emeritus of Eli Lilly and Co. Tobias will be back in Indianapolis for the dedication of the Tobias Center for Leadership Excellence, a new research and outreach initiative housed in IU's Kelley School of Business in Indianapolis.
› Verified 7 days ago
| Entity Name | Group Health Plan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710924683 PECOS PAC ID: 1759293954 Enrollment ID: O20031105000417 |
News Archive
Researchers at the Swansea University have shown that Manuka honey could be useful in treatment of deadly lung infections caused by antimicrobial resistant respiratory bacteria in cystic fibrosis (CF). The study titled, "Anti-pseudomonad Activity of Manuka Honey and Antibiotics in a Specialized ex vivo Model Simulating Cystic Fibrosis Lung Infection," was published in the latest issue of the journal Frontiers of Microbiology.
GenomeDx Biosciences today announced that data presented at the 2015 American Society of Clinical Oncology Annual Meeting demonstrate that the Decipher® Prostate Cancer Classifier is a significant predictor of metastasis in patients treated with postoperative salvage radiation therapy.
Corcept Therapeutics Incorporated, a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, today announced results of a multi-center Phase 1/2 dose-escalation study of mifepristone and chemotherapy drug eribulin (Halaven) that show it is well tolerated and clinically active in patients with triple-negative breast cancer.
Cell-based therapies have yet to reach their full potential in repairing damaged tissue because of the hostile environment the cells face once injected into the body. A patient's inflammatory response normally causes the majority of these therapeutic cells to die or migrate away from the area in need of repair.
Indiana University has arranged for a media availability on Monday (May 10) at 1:30 p.m. in Indianapolis with Randall L. Tobias, U.S. Global AIDS coordinator and chairman emeritus of Eli Lilly and Co. Tobias will be back in Indianapolis for the dedication of the Tobias Center for Leadership Excellence, a new research and outreach initiative housed in IU's Kelley School of Business in Indianapolis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Bethany Anne Thompson, APRN, CNM 8170 33rd Ave S, Ms 21110q, Bloomington, MN 55425-1614 Ph: () - | Mrs Bethany Anne Thompson, APRN, CNM 601 Jacob Ln, Anoka, MN 55303-1776 Ph: (763) 587-4200 |
News Archive
Researchers at the Swansea University have shown that Manuka honey could be useful in treatment of deadly lung infections caused by antimicrobial resistant respiratory bacteria in cystic fibrosis (CF). The study titled, "Anti-pseudomonad Activity of Manuka Honey and Antibiotics in a Specialized ex vivo Model Simulating Cystic Fibrosis Lung Infection," was published in the latest issue of the journal Frontiers of Microbiology.
GenomeDx Biosciences today announced that data presented at the 2015 American Society of Clinical Oncology Annual Meeting demonstrate that the Decipher® Prostate Cancer Classifier is a significant predictor of metastasis in patients treated with postoperative salvage radiation therapy.
Corcept Therapeutics Incorporated, a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, today announced results of a multi-center Phase 1/2 dose-escalation study of mifepristone and chemotherapy drug eribulin (Halaven) that show it is well tolerated and clinically active in patients with triple-negative breast cancer.
Cell-based therapies have yet to reach their full potential in repairing damaged tissue because of the hostile environment the cells face once injected into the body. A patient's inflammatory response normally causes the majority of these therapeutic cells to die or migrate away from the area in need of repair.
Indiana University has arranged for a media availability on Monday (May 10) at 1:30 p.m. in Indianapolis with Randall L. Tobias, U.S. Global AIDS coordinator and chairman emeritus of Eli Lilly and Co. Tobias will be back in Indianapolis for the dedication of the Tobias Center for Leadership Excellence, a new research and outreach initiative housed in IU's Kelley School of Business in Indianapolis.
› Verified 7 days ago
Julie Michelle Edinger, APRN Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 606 Oakwood Dr, Anoka, MN 55303 Phone: 763-568-9810 | |
Deka Ahmed Abdulle, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 601 Jacob Lane, Mail Stop 39300a, Anoka, MN 55303 Phone: 763-587-4200 | |
Ms. Valor Hopes, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 601 Jacob Ln, Anoka, MN 55303 Phone: 763-587-4200 Fax: 763-587-4205 | |
Regina Marie Browne, APRN, CNM, WHNP-BC Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 601 Jacob Ln, Anoka, MN 55303 Phone: 763-587-4200 |